Speed of improvement in cancer survival rates ‘slowing', say experts
A national cancer plan was 'essential' to 'bring cancer survival trends back towards the best in the world', researchers said.
The study, led by the London School of Hygiene and Tropical Medicine (LSHTM) and funded by Cancer Research UK, analysed long-term trends in the cancer survival index (CSI) for adults across England and Wales from 1971 to 2018.
Using records from the National Disease Registration Service for England and the Welsh Cancer Intelligence and Surveillance Unit, experts estimated net survival for up to 10 years after diagnosis for around 10.8 million people.
They found that in 2018, the CSI for all cancers combined a decade after diagnosis was 49.8%, higher than the CSI at one year for those diagnosed in 1971/72.
Researchers hailed the figure as 'remarkable', but warned that the 'speed of improvement in survival has slowed down'.
In the five years from 2000/01 to 2005/06, the 10-year CSI rose by 4%, from 41.2% to 45.2%.
But between 2010/11 and 2015/16, the rise was 1.4%, from 47.9% to 49.3%.
There were also major gaps in survival when it came to different cancer types.
For example, 10-year survival for testicular cancer was 97%, compared with 4.3% for pancreatic cancer.
Screening programmes had bolstered survival rates for cancers in the breast, bowel and cervix, according to Cancer Research UK.
But survival for other types, such as stomach, lung and brain cancer, had increased by only a small amount in the past 50 years.
Writing in the Lancet Regional Health – Europe, researchers warned this slowdown for individual cancers implied a 'system-wide challenge'.
Michelle Mitchell, chief executive of Cancer Research UK, said: 'Thanks to research, most patients today are far more likely to survive their cancer than at any point in the past.
'But the reality is that this progress is slowing – and for some cancers, it never got going in the first place.'
The Government launched a call for evidence to help shape a national cancer plan in February.
The blueprint aims to outline actions to transform how the disease is treated in a bid to reduce deaths.
Ms Mitchell said: 'The upcoming National Cancer Plan for England must include commitments to spot more cancers earlier, as well as backing research into new treatments so that each patient, regardless of their diagnosis, can hope for more moments with the people they love.'
Michel Coleman, a professor of epidemiology and statistics at LSHTM, said: 'Since I began my career in cancer research, I've seen substantial increases in survival for most types of cancer.
'Our understanding of cancer biology has expanded, effective screening programmes have been introduced, and new treatments have been developed. Allowing this trend to stall will have devastating consequences.
'This study was only possible because of data on millions of patients from cancer registries in England and Wales.
'It's vital that the Government provides the political and financial support to ensure we maintain this crucial data. Without these, the Government will be flying blind on cancer control.
'The National Cancer Plan is a chance to improve NHS cancer pathways and reap the benefits of new research – the Government must take it.'
Cancer Research UK is calling for the national cancer plan to slash waiting times for diagnosis and treatment, saying some patients face unacceptable delays.
The plan should also improve early diagnosis of cancer, with plans to boost participation in existing screening programmes and a commitment to rolling out lung cancer screening fully in England by 2029.
A Department of Health and Social Care spokesperson said: 'We are prioritising cancer care as we turn around more than a decade of neglect of our NHS.
'We're already seeing progress, with 95,000 more people having cancer diagnosed or ruled out within 28 days between July 2024 and May 2025, compared to the same period the previous year.
'The National Cancer Plan will set out how we will improve survival rates further and address the variation between different cancer types.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
4 hours ago
- BBC News
The deadly cancers left behind by 50 years of success
The number of people surviving cancer has improved hugely in the past 50 years, but experts warn progress has been uneven with some of the cancers with the worst survival rates falling further some, including melanoma skin cancer, 10-year survival is now above 90%, while for all cancers, half of patients can expect to live that long - double the figure in the early a study by the London School of Hygiene and Tropical Medicine said there had been little improvement in those affecting the oesophagus, stomach and lungs - and less than 5% survive pancreatic cancer for 10 government said it was committed to making more progress with a new strategy due soon. The researchers said advances in treatment and earlier detection were behind the improvements in survival seen for many cancer is a perfect example of this, with 10-year survival rates rising from 42% to more than 76% between 1971 and 2018 in England and period saw the introduction of an NHS breast screening programme, plus targeted therapies for different types of breast comparison, the cancers with the lowest survival rates tend to be the hardest to detect and have the fewest treatment pancreatic cancer, the study says these include oesophagus, stomach and lung cancers, which all still have 10-year survival rates below 20%, after only a small amount of progress since the has meant the gap between the cancers with the best and worst survival rates has nearly doubled. 'Amazing job' Matt Black is someone with first-hand experience of how the type of cancer you get makes a huge 2019 the 60-year-old lost his sister, Harriette, to pancreatic cancer, 20 years after his father-in-law died of oesophageal years ago he was diagnosed with bowel cancer which has above average survival rates. Soon after developing symptoms he had surgery and was given the all-clear."NHS staff do an amazing job, but it's such a difficult time to be a cancer patient, especially for those with cancers which aren't easy to spot or treat. "It's so important that there is more research and support for cancer services here, so that more people can be as fortunate as me," says Matt. The researchers also warned that, while overall survival was still improving, the rate of progress had slowed during the 2010s. Longer waits for diagnosis and treatment are thought to be partly to blame. Michelle Mitchell, chief executive of Cancer Research UK, which funded the study, said: "Thanks to research, most patients today are far more likely to survive cancer than at any other point in the past."But the reality is that this progress is slowing – and for some cancers it never got going in the first place."The charity wants the government's forthcoming strategy to focus on:cutting waiting timesearly detection, including full introduction of a lung cancer screening programmeinvestment in research, particularly targeting the most deadly cancersA Department of Health and Social Care spokesman said cancer care was a priority. with some progress already made on waiting times."The national cancer plan will set out how we will improve survival rates further and address the unacceptable variation between different cancer types," he added.
South Wales Guardian
6 hours ago
- South Wales Guardian
Speed of improvement in cancer survival rates ‘slowing', say experts
The news comes as a study suggests survival between the most and least deadly types of the disease is wider than ever before. A national cancer plan was 'essential' to 'bring cancer survival trends back towards the best in the world', researchers said. The study, led by the London School of Hygiene and Tropical Medicine (LSHTM) and funded by Cancer Research UK, analysed long-term trends in the cancer survival index (CSI) for adults across England and Wales from 1971 to 2018. Using records from the National Disease Registration Service for England and the Welsh Cancer Intelligence and Surveillance Unit, experts estimated net survival for up to 10 years after diagnosis for around 10.8 million people. They found that in 2018, the CSI for all cancers combined a decade after diagnosis was 49.8%, higher than the CSI at one year for those diagnosed in 1971/72. Researchers hailed the figure as 'remarkable', but warned that the 'speed of improvement in survival has slowed down'. In the five years from 2000/01 to 2005/06, the 10-year CSI rose by 4%, from 41.2% to 45.2%. But between 2010/11 and 2015/16, the rise was 1.4%, from 47.9% to 49.3%. There were also major gaps in survival when it came to different cancer types. For example, 10-year survival for testicular cancer was 97%, compared with 4.3% for pancreatic cancer. Screening programmes had bolstered survival rates for cancers in the breast, bowel and cervix, according to Cancer Research UK. But survival for other types, such as stomach, lung and brain cancer, had increased by only a small amount in the past 50 years. Writing in the Lancet Regional Health – Europe, researchers warned this slowdown for individual cancers implied a 'system-wide challenge'. Michelle Mitchell, chief executive of Cancer Research UK, said: 'Thanks to research, most patients today are far more likely to survive their cancer than at any point in the past. 'But the reality is that this progress is slowing – and for some cancers, it never got going in the first place.' The Government launched a call for evidence to help shape a national cancer plan in February. The blueprint aims to outline actions to transform how the disease is treated in a bid to reduce deaths. Ms Mitchell said: 'The upcoming National Cancer Plan for England must include commitments to spot more cancers earlier, as well as backing research into new treatments so that each patient, regardless of their diagnosis, can hope for more moments with the people they love.' Michel Coleman, a professor of epidemiology and statistics at LSHTM, said: 'Since I began my career in cancer research, I've seen substantial increases in survival for most types of cancer. 'Our understanding of cancer biology has expanded, effective screening programmes have been introduced, and new treatments have been developed. Allowing this trend to stall will have devastating consequences. 'This study was only possible because of data on millions of patients from cancer registries in England and Wales. 'It's vital that the Government provides the political and financial support to ensure we maintain this crucial data. Without these, the Government will be flying blind on cancer control. 'The National Cancer Plan is a chance to improve NHS cancer pathways and reap the benefits of new research – the Government must take it.' Cancer Research UK is calling for the national cancer plan to slash waiting times for diagnosis and treatment, saying some patients face unacceptable delays. The plan should also improve early diagnosis of cancer, with plans to boost participation in existing screening programmes and a commitment to rolling out lung cancer screening fully in England by 2029. A Department of Health and Social Care spokesperson said: 'We are prioritising cancer care as we turn around more than a decade of neglect of our NHS. 'We're already seeing progress, with 95,000 more people having cancer diagnosed or ruled out within 28 days between July 2024 and May 2025, compared to the same period the previous year. 'The National Cancer Plan will set out how we will improve survival rates further and address the variation between different cancer types.'
North Wales Chronicle
6 hours ago
- North Wales Chronicle
Speed of improvement in cancer survival rates ‘slowing', say experts
The news comes as a study suggests survival between the most and least deadly types of the disease is wider than ever before. A national cancer plan was 'essential' to 'bring cancer survival trends back towards the best in the world', researchers said. The study, led by the London School of Hygiene and Tropical Medicine (LSHTM) and funded by Cancer Research UK, analysed long-term trends in the cancer survival index (CSI) for adults across England and Wales from 1971 to 2018. Using records from the National Disease Registration Service for England and the Welsh Cancer Intelligence and Surveillance Unit, experts estimated net survival for up to 10 years after diagnosis for around 10.8 million people. They found that in 2018, the CSI for all cancers combined a decade after diagnosis was 49.8%, higher than the CSI at one year for those diagnosed in 1971/72. Researchers hailed the figure as 'remarkable', but warned that the 'speed of improvement in survival has slowed down'. In the five years from 2000/01 to 2005/06, the 10-year CSI rose by 4%, from 41.2% to 45.2%. But between 2010/11 and 2015/16, the rise was 1.4%, from 47.9% to 49.3%. There were also major gaps in survival when it came to different cancer types. For example, 10-year survival for testicular cancer was 97%, compared with 4.3% for pancreatic cancer. Screening programmes had bolstered survival rates for cancers in the breast, bowel and cervix, according to Cancer Research UK. But survival for other types, such as stomach, lung and brain cancer, had increased by only a small amount in the past 50 years. Writing in the Lancet Regional Health – Europe, researchers warned this slowdown for individual cancers implied a 'system-wide challenge'. Michelle Mitchell, chief executive of Cancer Research UK, said: 'Thanks to research, most patients today are far more likely to survive their cancer than at any point in the past. 'But the reality is that this progress is slowing – and for some cancers, it never got going in the first place.' The Government launched a call for evidence to help shape a national cancer plan in February. The blueprint aims to outline actions to transform how the disease is treated in a bid to reduce deaths. Ms Mitchell said: 'The upcoming National Cancer Plan for England must include commitments to spot more cancers earlier, as well as backing research into new treatments so that each patient, regardless of their diagnosis, can hope for more moments with the people they love.' Michel Coleman, a professor of epidemiology and statistics at LSHTM, said: 'Since I began my career in cancer research, I've seen substantial increases in survival for most types of cancer. 'Our understanding of cancer biology has expanded, effective screening programmes have been introduced, and new treatments have been developed. Allowing this trend to stall will have devastating consequences. 'This study was only possible because of data on millions of patients from cancer registries in England and Wales. 'It's vital that the Government provides the political and financial support to ensure we maintain this crucial data. Without these, the Government will be flying blind on cancer control. 'The National Cancer Plan is a chance to improve NHS cancer pathways and reap the benefits of new research – the Government must take it.' Cancer Research UK is calling for the national cancer plan to slash waiting times for diagnosis and treatment, saying some patients face unacceptable delays. The plan should also improve early diagnosis of cancer, with plans to boost participation in existing screening programmes and a commitment to rolling out lung cancer screening fully in England by 2029. A Department of Health and Social Care spokesperson said: 'We are prioritising cancer care as we turn around more than a decade of neglect of our NHS. 'We're already seeing progress, with 95,000 more people having cancer diagnosed or ruled out within 28 days between July 2024 and May 2025, compared to the same period the previous year. 'The National Cancer Plan will set out how we will improve survival rates further and address the variation between different cancer types.'
